Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Chaman Saini, Praveen Kumar, Mohd Tarique, Alpana Sharma & Venkatesh Ramesh. (2018) Regulatory T cells antagonize proinflammatory response of IL-17 during cutaneous tuberculosis. Journal of Inflammation Research 11, pages 377-388.
Read now
Read now
Yuan-qiang Zheng, Youssef W Naguib, Yixuan Dong, Yan-chun Shi, Shorgan Bou & Zhengrong Cui. (2015) Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy. Expert Review of Vaccines 14:9, pages 1255-1275.
Read now
Read now
Paola Gastelum-Aviña, Carlos Velazquez, Clara Espitia, Fernando Lares-Villa & Adriana Garibay-Escobar. (2015) A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design. Expert Review of Vaccines 14:5, pages 699-711.
Read now
Read now
Dessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo & Carlos Martin. (2013) Recent developments in tuberculosis vaccines. Expert Review of Vaccines 12:12, pages 1431-1448.
Read now
Read now
Neha Dalmia & Alistair J Ramsay. (2012) Prime–boost approaches to tuberculosis vaccine development. Expert Review of Vaccines 11:10, pages 1221-1233.
Read now
Read now
Wolfgang M Thaiss, Cornelius C Thaiss & Christoph A Thaiss. (2012) Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?. Infection and Drug Resistance 5, pages 1-8.
Read now
Read now
Meghna Adhvaryu & Bhasker Vakharia. (2011) Drug-resistant tuberculosis: emerging treatment options. Clinical Pharmacology: Advances and Applications 3, pages 51-67.
Read now
Read now
David N McMurray. (2011) Do new TB vaccines have a place in the Expanded Program on Immunization?. Expert Review of Vaccines 10:12, pages 1675-1677.
Read now
Read now
Eleanor Barnes & Andrew J Pollard. (2011) Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10:5, pages 555-557.
Read now
Read now
Articles from other publishers (69)
Kenneth Barry Walker & Joanna Bacon. 2023. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
197
209
.
Pratiksha Prabhu, Trinette Fernandes, Mansi Damani, Pramila Chaubey, Shridhar Narayanan & Sujata Sawarkar. (2022) 2 Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy
for Targeted Therapy of Tuberculosis. Current Drug Delivery 19:8, pages 830-845.
Crossref
Crossref
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Junli Li, Jinbiao Lu, Guozhi Wang, Aihua Zhao & Miao Xu. (2022) Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China. Vaccines 10:7, pages 1157.
Crossref
Crossref
Rasul Hoseinpur, Alka Hasani, Behzad Baradaran, Jalal Abdolalizadeh, Yousef Amini, Roya Salehi, Hossein Samadi Kafil, Khalil Azizian, Mohammad Yousef Memar, Pourya Gholizadeh & Akbar Hasani. (2022)
Chitosan nanoparticles containing fusion protein (Hspx–PPE44–EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
Mycobacterium tuberculosis
. Journal of Biomaterials Applications 37:1, pages 40-47.
Crossref
Crossref
Radha Gopalaswamy & Selvakumar Subbian. 2022. Vaccine Design. Vaccine Design
387
409
.
Riya Madan, Kushankur Pandit, Lavi Bhati, Hindesh Kumar, Neha Kumari & Swati Singh. (2021) Mining the Mycobacterium tuberculosis proteome for identification of potential T-cell epitope based vaccine candidates. Microbial Pathogenesis 157, pages 104996.
Crossref
Crossref
Eman A. Toraih, Jessica A. Sedhom, Titilope M. Dokunmu, Mohammad H. Hussein, Emmanuelle M. L. Ruiz, Kunnimalaiyaan Muthusamy, Mourad Zerfaoui & Emad Kandil. (2020) Hidden in plain sight: The effects of BCG vaccination in the COVID‐19 pandemic. Journal of Medical Virology 93:4, pages 1950-1966.
Crossref
Crossref
Farheen Fatma, Dinesh K. Tripathi, Mrigank Srivastava, Kishore K. Srivastava & Ashish Arora. (2021) Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv. Tuberculosis 127, pages 102054.
Crossref
Crossref
Swati Vyas, Sagar Dhoble, Vinod Ghodake & V. Patravale. (2020) Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology. International Journal of Pharmaceutics: X 2, pages 100053.
Crossref
Crossref
Anna Jelińska, Marianna Zając, Adrianna Dadej, Szymon Tomczak, Małgorzata Geszke-Moritz & Izabela Muszalska-Kolos. (2020) Tuberculosis - Present Medication and Therapeutic Prospects. Current Medicinal Chemistry 27:4, pages 630-656.
Crossref
Crossref
Charlotte A. James & Chetan Seshadri. (2020) T Cell Responses to Mycobacterial Glycolipids: On the Spectrum of “Innateness”. Frontiers in Immunology 11.
Crossref
Crossref
Thomas Clarke, Lauren Brinkac, Joanna Manoranjan, Alberto García-Basteiro, Harleen Grewal, Anthony Kiyimba, Elisa Lopez, Ragini Macaden, Durval Respeito, Willy Ssengooba, Michele Tameris & Granger Sutton. (2020) Typing and classification of non-tuberculous mycobacteria isolates. F1000Research 9, pages 249.
Crossref
Crossref
Thomas Clarke, Lauren Brinkac, Joanna Manoranjan, Alberto García-Basteiro, Harleen Grewal, Anthony Kiyimba, Elisa Lopez, Ragini Macaden, Durval Respeito, Willy Ssengooba, Michele Tameris & Granger Sutton. (2020) Typing and classification of non-tuberculous mycobacteria isolates. F1000Research 9, pages 249.
Crossref
Crossref
Simone A. Joosten, Tom H.M. Ottenhoff, David M. Lewinsohn, Daniel F. Hoft, D. Branch Moody & Chetan Seshadri. (2019) Harnessing donor unrestricted T-cells for new vaccines against tuberculosis. Vaccine 37:23, pages 3022-3030.
Crossref
Crossref
J.S.V. Soundarya, Uma Devi Ranganathan & Srikanth P. Tripathy. (2019) Current trends in tuberculosis vaccine. Medical Journal Armed Forces India 75:1, pages 18-24.
Crossref
Crossref
Saeed Khoshnood, Mohsen Heidary, Mehri Haeili, Michel Drancourt, Davood Darban-Sarokhalil, Mohammad Javad Nasiri & Vahid Lohrasbi. (2018) Novel vaccine candidates against Mycobacterium tuberculosis. International Journal of Biological Macromolecules 120, pages 180-188.
Crossref
Crossref
Aarti Rana, Shweta Thakur, Girish Kumar & Yusuf Akhter. (2018) Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens. Frontiers in Genetics 9.
Crossref
Crossref
Sepehr Navid & Masoud Keikha. (2018) Can Fusion Proteins Be Considered a New Candidate for Tuberculosis Vaccine?. Gene, Cell and Tissue In Press:In Press.
Crossref
Crossref
Elisa Nemes, Anneke C Hesseling, Michele Tameris, Katya Mauff, Katrina Downing, Humphrey Mulenga, Penelope Rose, Marieke van der Zalm, Sharon Mbaba, Danelle Van As, Willem A Hanekom, Gerhard Walzl, Thomas J Scriba, Helen McShane, Mark Hatherill, Charmaine Abrahams, Deborah Abrahams, Hadn Africa, Veronica Baartman, Beauty Bavuma, Nicole Bilek, Natasja Botes, Yolande Brown, Yolundi Cloete, Margareth Damons, Ronel De Vos, Portia Dlakavu, Karen Du Preez, Mzwandile Erasmus, Claudia Francis, Hendrik Geldenhuys, Mandy Geldenhuys, Katriena Goedeman, Sandra Golliath, Angelique Hendricks Mouton, Christiaan Hopley, Ruwijda Jansen, Carolynne Jones, Alana Keyser, Benjamin Kagina, Gloria Khomba, Fazlin Kola–Cassiem, Sandra Kruger, Daphne Leukes, Loyiso Louw, Angelique Luabeya, Theresa Maart, Lebohang Makhethe, Simbarashe Mbabwe, Eunice Mtshamba, Boniswa Mvinjelwa, Lungisa Nkantsu, Julia Noble, Sizwe Nqweniso, Fajwa Opperman, Christel Petersen, Patiswa Plaatjie, Susan Rossouw, Roxanne Solomoms, Marcia Steyn, Liticia Swanepoel, Asma Toefy, Heidi van Deventer, Elma van Rooyen, Daphne van Ster, Bongiwe Vazana, Ashley Veldsman & Noncedo Xoyana. (2018) Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial. Clinical Infectious Diseases 66:4, pages 554-563.
Crossref
Crossref
Pradeep K. Rai, Sathi Babu Chodisetti, Weiguang Zeng, Sajid Nadeem, Sudeep K. Maurya, Susanta Pahari, Ashok K. Janmeja, David C. Jackson & Javed N. Agrewala. (2017) A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity. Journal of Translational Medicine 15:1.
Crossref
Crossref
S. M. Rozov & E. V. Deineko. (2017) Strategies for designing novel tuberculosis vaccines. Biology Bulletin Reviews 7:2, pages 113-128.
Crossref
Crossref
Theolis Costa Barbosa Bessa, Erika Santos de Aragão, Jane Mary Medeiros Guimarães & Bethânia de Araújo Almeida. (2017) R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014. BioMed Research International 2017, pages 1-12.
Crossref
Crossref
Guixiang Dai, Hamada F. Rady, Weitao Huang, Judd E. Shellito, Carol Mason & Alistair J. Ramsay. (2016) Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Vaccine 34:50, pages 6267-6275.
Crossref
Crossref
Nancy Gupta, Satish Vedi, Dennis Y. Kunimoto, Babita Agrawal & Rakesh Kumar. (2016) Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy. Vaccine 34:46, pages 5677-5688.
Crossref
Crossref
Jennifer Wong, Maurizio Ricci & Hak-Kim Chan. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
161
196
.
Dominique N. Price, Nitesh K. Kunda, Amber A. McBride & Pavan Muttil. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment
67
90
.
Alexey Anatolievich Rudko, Elena Yurievna Bragina, Valery Pavlovich Puzyrev & Maxim Borisovich Freidin. (2016) The genetics of susceptibility to tuberculosis: Progress and challenges. Asian Pacific Journal of Tropical Disease 6:9, pages 680-684.
Crossref
Crossref
Aliabbas A. Husain, Hatim F. Daginawala, Lokendra Singh & Rajpal S. Kashyap. (2016) Current perspective in tuberculosis vaccine development for high TB endemic regions. Tuberculosis 98, pages 149-158.
Crossref
Crossref
Soo Jung Son, Paul W. R. Harris, Chris J. Squire, Edward N. Baker & Margaret A. Brimble. (2016)
Synthesis and structural insight into ESX-1 Substrate Protein C, an immunodominant
Mycobacterium tuberculosis-
secreted antigen
. Biopolymers 106:3, pages 267-274.
Crossref
Crossref
Sandeep Kumar Dhanda, Pooja Vir, Deepak Singla, Sudheer Gupta, Shailesh Kumar & Gajendra P. S. Raghava. (2016) A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis. PLOS ONE 11:4, pages e0153771.
Crossref
Crossref
Anto Vrdoljak, Evin A. Allen, Francesca Ferrara, Nigel J. Temperton, Abina M. Crean & Anne C. Moore. (2016) Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods. Journal of Controlled Release 225, pages 192-204.
Crossref
Crossref
Aliabbas A. Husain, Hatim F. Daginawla, Lokendra Singh & Rajpal S. Kashyap. (2016) Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report. Clinical and Experimental Vaccine Research 5:1, pages 31.
Crossref
Crossref
Zhenhai Chen, Tuhina Gupta, Pei Xu, Shannon Phan, Adrian Pickar, Wilson Yau, Russell K. Karls, Frederick D. Quinn, Kaori Sakamoto & Biao He. (2015) Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice. Vaccine 33:51, pages 7217-7224.
Crossref
Crossref
Hyungki Lee, Byoung-Jun Kim, Bo-Ram Kim, Yoon-Hoh Kook & Bum-Joon Kim. (2015) The Development of a Novel Mycobacterium-Escherichia coli Shuttle Vector System Using pMyong2, a Linear Plasmid from Mycobacterium yongonense DSM 45126T. PLOS ONE 10:3, pages e0122897.
Crossref
Crossref
Jacob S. Heng, Alan Baird, Marco R. Novelli, Robert N. Davidson & Rajinder P. Bhutiani. (2015) Filiform Polyposis Secondary to Colonic Tuberculosis Presenting as Acute Colo-Colonic Intussusception. Case Reports in Surgery 2015, pages 1-4.
Crossref
Crossref
Maria Fernanda Reis Gavazzoni Dias, Fred Bernardes Filho, Maria Victória Quaresma, Leninha Valério do Nascimento, José Augusto da Costa Nery & David Rubem Azulay. (2014) Update on cutaneous tuberculosis. Anais Brasileiros de Dermatologia 89:6, pages 925-938.
Crossref
Crossref
Samuel M. Behar, Stephen M. Carpenter, Matthew G. Booty, Daniel L. Barber & Pushpa Jayaraman. (2014) Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: Immunity interruptus. Seminars in Immunology 26:6, pages 559-577.
Crossref
Crossref
S. Dhanasekaran, Synne Jenum, Ruth Stavrum, Harald G. Wiker, John Kenneth, Mario Vaz, T. Mark Doherty & Harleen M. S. Grewal. (2014) Effect of Non-tuberculous Mycobacteria on Host Biomarkers Potentially Relevant for Tuberculosis Management. PLoS Neglected Tropical Diseases 8:10, pages e3243.
Crossref
Crossref
M. Domingo, E. Vidal & A. Marco. (2014) Pathology of bovine tuberculosis. Research in Veterinary Science 97, pages S20-S29.
Crossref
Crossref
Patricia A. Darrah, Diane L. Bolton, Andrew A. Lackner, Deepak Kaushal, Pyone Pyone Aye, Smriti Mehra, James L. Blanchard, Peter J. Didier, Chad J. Roy, Srinivas S. Rao, David A. Hokey, Charles A. Scanga, Donata R. Sizemore, Jerald C. Sadoff, Mario Roederer & Robert A. Seder. (2014)
Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose
Mycobacterium tuberculosis
Challenge
. The Journal of Immunology 193:4, pages 1799-1811.
Crossref
Crossref
Zhiling Dong, Lei Xu, Jing Yang, Yonglin He, Qian She, Jingxian Wang, Zhuangmiao Zhang, Xin Feng, Dairong Li & Chun Yang. (2014) Primary application of PPE68 of Mycobacterium tuberculosis. Human Immunology 75:5, pages 428-432.
Crossref
Crossref
Mark T. Orr, Ryan M. Kramer, Lucien BarnesVV, Quinton M. Dowling, Anthony L. Desbien, Elyse A. Beebe, John D. Laurance, Christopher B. Fox, Steven G. Reed, Rhea N. Coler & Thomas S. Vedvick. (2014) Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization. Journal of Controlled Release 177, pages 20-26.
Crossref
Crossref
Niels Peter H. Knudsen, Sara Nørskov-Lauritsen, Gregory M. Dolganov, Gary K. Schoolnik, Thomas Lindenstrøm, Peter Andersen, Else Marie Agger & Claus Aagaard. (2014) Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics. Proceedings of the National Academy of Sciences 111:3, pages 1096-1101.
Crossref
Crossref
Mark T. Orr, Elyse A. Beebe, Thomas E. Hudson, James J. Moon, Christopher B. Fox, Steven G. Reed & Rhea N. Coler. (2014) A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93. PLoS ONE 9:1, pages e83884.
Crossref
Crossref
Jae-Min Yuk & Eun-Kyeong Jo. (2014) Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis. Clinical and Experimental Vaccine Research 3:2, pages 155.
Crossref
Crossref
Jean-Pierre ZellwegerRosalind RowlandHelen McShane. 2014. Clinical Insights: Tuberculosis Prevention. Clinical Insights: Tuberculosis Prevention
33
52
.
B. M. Buddle, N. A. Parlane, D. N. Wedlock & A. Heiser. (2013) Overview of Vaccination Trials for Control of Tuberculosis in Cattle, Wildlife and Humans. Transboundary and Emerging Diseases 60, pages 136-146.
Crossref
Crossref
Fiona SmaillMangalakumari JeyanathanMarek SmiejaMaria Fe MedinaNiroshan Thanthrige-DonAnna ZganiaczCindy YinArmando HeriazonDaniela DamjanovicLaura PuriJemila HamidFeng XieRonan FoleyJonathan BramsonJack GauldieZhou Xing. (2013) A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine 5:205.
Crossref
Crossref
Anderson R Santos, Vanessa Bastos Pereira, Eudes Barbosa, Jan Baumbach, Josch Pauling, Richard Röttger, Meritxell Zurita Turk, Artur Silva, Anderson Miyoshi & Vasco Azevedo. (2013) Mature Epitope Density - A strategy for target selection based on immunoinformatics and exported prokaryotic proteins. BMC Genomics 14:S6.
Crossref
Crossref
Susan L. Baldwin, Lance K. Ching, Samuel O. Pine, Magdalini Moutaftsi, Elyse Lucas, Aarthy Vallur, Mark T. Orr, Sylvie Bertholet, Steven G. Reed & Rhea N. Coler. (2013) Protection against Tuberculosis with Homologous or Heterologous Protein/Vector Vaccine Approaches Is Not Dependent on CD8+ T Cells. The Journal of Immunology 191:5, pages 2514-2525.
Crossref
Crossref
Thomas Lindenstrøm, Niels Peter Hell Knudsen, Else Marie Agger & Peter Andersen. (2013)
Control of Chronic
Mycobacterium tuberculosis
Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells
. The Journal of Immunology 190:12, pages 6311-6319.
Crossref
Crossref
Hilary S Whitworth, Elihu Aranday-Cortes & Ajit Lalvani. (2013) Biomarkers of tuberculosis: a research roadmap. Biomarkers in Medicine 7:3, pages 349-362.
Crossref
Crossref
Jonathan M. Pitt, Simon Blankley, Helen McShane & Anne O'Garra. (2013) Vaccination against tuberculosis: How can we better BCG?. Microbial Pathogenesis 58, pages 2-16.
Crossref
Crossref
Julie Todoroff, Bernard Ucakar, Malory Inglese, Sophie Vandermarliere, Catherine Fillee, Jean-Christophe Renauld, Kris Huygen & Rita Vanbever. (2013) Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery. European Journal of Pharmaceutics and Biopharmaceutics 84:1, pages 40-48.
Crossref
Crossref
Chetan Seshadri, Marie T. Turner, David M. Lewinsohn, D. Branch Moody & Ildiko Van Rhijn. (2013)
Lipoproteins Are Major Targets of the Polyclonal Human T Cell Response to
Mycobacterium tuberculosis
. The Journal of Immunology 190:1, pages 278-284.
Crossref
Crossref
In Soon RohSungae ChoSeok-Yong EumSang-Nae Cho. (2013)
Kinetics of IFN-Gamma and TNF-Alpha Gene Expression and Their Relationship with Disease Progression after Infection with
Mycobacterium Tuberculosis
in Guinea Pigs
. Yonsei Medical Journal 54:3, pages 707.
Crossref
Crossref
Naomi F Walker, Graeme Meintjes & Robert J Wilkinson. (2013) HIV-1 and the immune response to TB. Future Virology 8:1, pages 57-80.
Crossref
Crossref
Alan W. Baird, Michael J. Rathbone & David J. Brayden. 2013. Long Acting Animal Health Drug Products. Long Acting Animal Health Drug Products
359
375
.
Alemnew F Dagnew, Jemal Hussein, Markos Abebe, Martha Zewdie, Adane Mihret, Ahmed Bedru, Menberework Chanyalew, Lawrence Yamuah, Girmay Medhin, Peter Bang, T Mark Doherty, Asrat Hailu & Abraham Aseffa. (2012) Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC Research Notes 5:1.
Crossref
Crossref
Kristopher Kolibab, Steven C. Derrick, William R. Jacobs & Sheldon L. Morris. (2012) Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations. Journal of Microbiological Methods 90:3, pages 245-249.
Crossref
Crossref
A. Zelmer, P. Carroll, N. Andreu, K. Hagens, J. Mahlo, N. Redinger, B. D. Robertson, S. Wiles, T. H. Ward, T. Parish, J. Ripoll, G. J. Bancroft & U. E. Schaible. (2012) A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. Journal of Antimicrobial Chemotherapy 67:8, pages 1948-1960.
Crossref
Crossref
Dmytro A Butov, Yuri V Efremenko, Natalia D Prihoda, Larisa I Yurchenko, Nina I Sokolenko, Olga V Arjanova, Anna L Stepanenko, Tatiana S Butova, Svetlana S Zaitzeva, Vichai Jirathitikal, Aldar S Bourinbaiar & Galyna A Kutsyna. (2012) Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV. Immunotherapy 4:7, pages 687-695.
Crossref
Crossref
Susan L. Baldwin, Sylvie Bertholet, Valerie A. Reese, Lance K. Ching, Steven G. Reed & Rhea N. Coler. (2012) The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine. The Journal of Immunology 188:5, pages 2189-2197.
Crossref
Crossref
Micha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, Hartmut Hengel, Emil C. Reisinger & Uwe K. Zettl. (2012) Vaccination against infection in patients with multiple sclerosis. Nature Reviews Neurology 8:3, pages 143-151.
Crossref
Crossref
W. Ray Waters, Mitchell V. Palmer, Bryce M. Buddle & H. Martin Vordermeier. (2012) Bovine tuberculosis vaccine research: Historical perspectives and recent advances. Vaccine 30:16, pages 2611-2622.
Crossref
Crossref
Hassan Mahomed & P. Bernard Fourie. (2012) Clinical trials of TB vaccines: Harmonization and cooperation. Tuberculosis 92, pages S21-S24.
Crossref
Crossref
Aparna Josephine Christy, Karthika Dharman, Gayatri Dhandapaani, Kannan Palaniyandi, Umesh D. Gupta, Pushpa Gupta, S. Ignacimuthu & Sujatha Narayanan. (2012) Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice. Vaccine 30:7, pages 1364-1370.
Crossref
Crossref
Stefan HE KaufmannSyed HuqPeter DO Davies. 2011. Current & Emerging Diagnostics, Therapeutics & Vaccines for Tuberculosis. Current & Emerging Diagnostics, Therapeutics & Vaccines for Tuberculosis
8
21
.